Abstract
Major depressive disorders (MDD) are among the most common psychiatric disorders affecting people worldwide. The steady increase in cases of depressive disorders has been mainly attributed to enhanced life stress. The association of this clinical condition with other systemic disorders, especially cardiac conditions, raises concerns about increased morbidity and mortality related to this disorder. Investigating neuro-cardiac regulation using heart rate variability (HRV) and cortical excitability using transcranial magnetic stimulation (TMS) in patients with depression can provide crucial insights to understand systemic involvement and possible therapeutic interventions. We recruited 60 patients suffering from moderate depression based on International Classification of Diseases ICD-10 criteria on treatment with Escitalopram for more than 2 months. The HRV measures and TMS techniques using cortical excitability measures with single and paired-pulse TMS measures were performed on all the patients and compared with age- and gender-matched healthy controls. Patients with depression showed significantly lesser standard deviation of normal-to-normal interval (SDNN), root mean square of successive differences (RMSSD), total power (TP), high frequency (HF) power, and increased low frequency (LF) power and LF/HF ratio which together indicate reduced HRV. Reduced short-interval intracortical inhibition (SICI), intracortical facilitation (ICF), and cortical silent period (CSP) (assessed by TMS) were also observed in patients with depression compared to healthy controls. Patients with depression showed decreased HRV, glutamatergic activity, gamma amino butyric acid-B (GABA-B) activity, and increased GABA-A activity. These findings suggest aberrant neuro-cardiac regulation and cortical excitability in this enigmatic disorder.
Similar content being viewed by others
Data Availability
The datasets during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Code Availability
Not applicable.
References
NIMH. May 2016. Achieved from the original on 5 August 2016. Retrieved 31 July2016.
WHO. Health statistics and information systems – estimates till 31st March 2023, [website]. Geneva: World Health Organization,2023 (http://www.who.int/healthinfo/global_burden_disease/estimates/en/).
Depression and other common mental disorders: global health estimates. Geneva: World Health Organization; 2017 http://apps.who.int/iris/handle/10665/254610
Institute of Health metrics and evaluation. Global health data exchange (GHDx), (Accessed 4th March 2023).
Hare DL, Toukhsati SR, Johansson P, Jaarsma T. Depression and cardiovascular disease: a clinical review. Eur Heart J. 2014;35:1365–72. https://doi.org/10.1093/eurheartj/eht462.
Kemp AH, Quintana DS, Felmingham KL, Matthews S, Jelinek HF. Depression, comorbid anxiety disorders, and heart rate variability in physically healthy, unmedicated patients: implications for cardiovascular risk. PLoS One. 2012;7:e30777. https://doi.org/10.1371/journal.pone.0030777.
Shinba T. Altered autonomic activity and reactivity in depression revealed by heart-rate variability measurement during rest and task conditions. Psychiatry Clin Neurosci. 2014;68:225–33. https://doi.org/10.1111/pcn.12123.
Udupa K, Sathyaprabha TN, Thirthalli J, Kishore KR, Lavekar GS, Raju TR, Gangadhar BN. Alteration of cardiac autonomic functions in patients with major depression: a study using heart rate variability measures. J Affect Disord. 2007;100:137–41. https://doi.org/10.1016/j.jad.2006.10.007.
Koch C, Wilhelm M, Salzmann S, Rief W, Euteneuer F. A meta-analysis of heart rate variability in major depression. Psychol Med. 2019;49:1948–57. https://doi.org/10.1017/S0033291719001351.
Hasan A, Falkai P, Wobrock T. Transcranial brain stimulation in Schizophrenia: targeting cortical excitability, connectivity and plasticity. Curr Med Chem. 2013;20:405–13.
Gabbay V, Bradley KA, Mao X, Ostrover R, Kang G, Shungu DC. Anterior cingulate cortex γ-aminobutyric acid deficits in youth with depression. Transl Psychiatry. 2017;7:e1216–e1216. https://doi.org/10.1038/tp.2017.187.
Sanacora G, Treccani G, Popoli M. Towards a glutamate hypothesis of depression. Neuropharmacology. 2012;62:63–77. https://doi.org/10.1016/j.neuropharm.2011.07.036.
Kinjo M, Wada M, Nakajima S, Tsugawa S, Nakahara T, Blumberger DM, Mimura M, Noda Y. Transcranial magnetic stimulation neurophysiology of patients with major depressive disorder: a systematic review and meta-analysis. Psychol Med. 2021;51:1–10. https://doi.org/10.1017/S0033291720004729.
Kashigar A, Udupa K, Fish J, Chen R. Neurophysiological assessment of fatigue in electrical injury patients. Exp Brain Res. 2014;232:1013–23. https://doi.org/10.1007/s00221-013-3812-x.
Jakhar J, Mehta UM, Ektare A, Vidyasagar PD, Varambally S, Thirthalli J, Gangadhar BN. Cortical inhibition in major depression: investigating the acute effect of single-session yoga versus walking. Brain Stimul. 2019;12:1597–9. https://doi.org/10.1016/j.brs.2019.07.029.
World Health Organization. (2004). ICD-10: international statistical classification of diseases and related health problems: tenth revision, 2nd ed. World Health Organization. https://apps.who.int/iris/handle/10665/42980.
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62.
Quintana DS, Alvares GA, Heathers JA. Guidelines for reporting articles on psychiatry and heart rate variability (GRAPH): recommendations to advance research communication. Transl Psychiatry. 2016;6(5):e803. https://doi.org/10.1038/tp.2016.73.
Udupa K. Transcranial magnetic stimulation in exploring neurophysiology of cortical circuits and potential clinical implications. Indian J Physiol Pharmacol. 2020;64(4):244–57.
Chen R, Berardelli A, Bhattacharya A, Bologna M, Chen KS, Fasano A, Helmich RC, Hutchison WD, Kamble N, Kühn AA, Macerollo A, Neumann WJ, Pal PK, Paparella G, Suppa A, Udupa K. Clinical neurophysiology of Parkinson’s disease and parkinsonism. Clin Neurophysiol Pract. 2022;30(7):201–27. https://doi.org/10.1016/j.cnp.2022.06.002.
Chen R, Cros D, Curra A, Di Lazzaro V, Lefaucheur JP, Magistris MR, Mills K, Rösler KM, Triggs WJ, Ugawa Y, Ziemann U. The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee. Clin Neurophysiol. 2008;119(3):504–32. https://doi.org/10.1016/j.clinph.2007.10.014.
Murburg MM, McFall ME, Lewis N, Veith RC. Plasma norepinephrine kinetics in patients with posttraumatic stress disorder. Biol Psychiatry. 1995;38:819–25. https://doi.org/10.1016/0006-3223(95)00044-5.
Barnes RF, Veith RC, Borson S, Verhey J, Raskind MA, Halter JB. High levels of plasma catecholamines in dexamethasone-resistant depressed patients. Am J Psychiatry. 1983;140:1623–5. https://doi.org/10.1176/ajp.140.12.1623.
Roy A, Pickar D, Linnoila M, Potter WZ. Plasma norepinephrine level in affective disorders Relationship to melancholia. Arch Gen Psychiatry. 1985;42:1181–5. https://doi.org/10.1001/archpsyc.1985.01790350055010.
Rubin AL, Price LH, Charney DS, Heninger GR. Noradrenergic function and the cortisol response to dexamethasone in depression. Psychiatry Res. 1985;15:5–15. https://doi.org/10.1016/0165-1781(85)90034-4.
Nemeroff CB, Widerlöv E, Bissette G, Walléus H, Karlsson I, Eklund K, Kilts CD, Loosen PT, Vale W. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science. 1984;226:1342–4. https://doi.org/10.1126/science.6334362.
Jeng J-S, Li C-T, Lin H-C, Tsai S-J, Bai Y-M, Su T-P, Chang Y-W, Cheng C-M. Antidepressant-resistant depression is characterized by reduced short- and long-interval cortical inhibition. Psychol Med. 2020;50:1285–91. https://doi.org/10.1017/S0033291719001223.
Radhu N, de Jesus DR, Ravindran LN, Zanjani A, Fitzgerald PB, Daskalakis ZJ. A meta-analysis of cortical inhibition and excitability using transcranial magnetic stimulation in psychiatric disorders. Clin Neurophysiol. 2013;124:1309–20. https://doi.org/10.1016/j.clinph.2013.01.014.
Bajbouj M, Lisanby SH, Lang UE, Danker-Hopfe H, Heuser I, Neu P. Evidence for impaired cortical inhibition in patients with unipolar major depression. Biol Psychiatry. 2006;59:395–400. https://doi.org/10.1016/j.biopsych.2005.07.036.
Lefaucheur JP, Lucas B, Andraud F, Hogrel JY, Bellivier F, Del Cul A, Rousseva A, Leboyer M, Paillère-Martinot ML. Inter-hemispheric asymmetry of motor corticospinal excitability in major depression studied by transcranial magnetic stimulation. J Psychiatr Res. 2008;42:389–98. https://doi.org/10.1016/j.jpsychires.2007.03.001.
Veronezi BP, Moffa AH, Carvalho AF, Galhardoni R, Simis M, Benseñor IM, Lotufo PA, Machado-Vieira R, Daskalakis ZJ, Brunoni AR. Evidence for increased motor cortical facilitation and decreased inhibition in atypical depression. Acta Psychiatr Scand. 2016;134:172–82. https://doi.org/10.1111/acps.12565.
Bentzen BH, Grunnet M. Central and peripheral GABA(A) receptor regulation of the heart rate depends on the conscious state of the animal. Adv Pharmacol Sci. 2011;2011:578273. https://doi.org/10.1155/2011/578273.
Giurgi-Oncu C, Tudoran C, Enatescu VR, Tudoran M, Pop GN, Bredicean C. Evolution of heart rate variability and heart rate turbulence in patients with depressive illness treated with selective serotonin reuptake inhibitors. Medicina (Kaunas). 2020;56(11):590. https://doi.org/10.3390/medicina56110590.
Udupa K, Thirthalli J, Sathyaprabha T, Kishore K, Raju T, Gangadhar B. Differential actions of antidepressant treatments on cardiac autonomic alterations in depression: a prospective comparison. Asian J Psychiatr. 2011;4(2):100–6. https://doi.org/10.1016/j.ajp.2011.02.006.
Funding
The authors would like to acknowledge the support of CCRAS (Central Council for Research and Ayurveda Sciences) for providing fellowship to the first author (JVS) and the DST SERB grant (EMR/2015/000209) which enabled us to collect healthy control data.
Author information
Authors and Affiliations
Contributions
JVS collected and analyzed neurophysiological data and drafted the initial manuscript taking inputs from all the authors; KKR, UM, SSV, STN, and KU provided the supervision. All authors read, edited, and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics Approval
The study was carried out in the Department of Neurophysiology in collaboration with Dept of Psychiatry, NIMHANS. The Institute Ethics Committee approval was obtained for the study (NIMHANS/HECCAIM meeting/2020–21 Dated 15.12.2020) and this study was registered under the Clinical Trial Registry of India (CTRI/2021/01/030417 dated 12.01.32021).
Consent to Participate
Written informed consent and assent were obtained before recruiting the subjects for the study.
Consent for Publication
All authors acknowledge their contribution and provide consent for the publication.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jismi, V.S., Ramakrishna, K.K., Mehta, U.M. et al. Investigating Neurocardiac Autonomic Regulation and Cortical Excitability Measures in Patients with Major Depressive Disorder. SN Compr. Clin. Med. 6, 44 (2024). https://doi.org/10.1007/s42399-024-01674-6
Accepted:
Published:
DOI: https://doi.org/10.1007/s42399-024-01674-6